Alexion Pharmaceuticals, Inc.

📍 Boston, United States🗓 Founded 1992👥 4,863 employees💰 Last funded 2018
Biotechnology Research🌐 alexion.com
Website LinkedIn
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1992
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Alexion Pharmaceuticals, Inc.?
Alexion Pharmaceuticals, Inc. has 1 investors on record on gritt.io.
When did Alexion Pharmaceuticals, Inc. last raise funding?
The most recent investment in Alexion Pharmaceuticals, Inc. recorded on gritt.io was in 2018.
When was Alexion Pharmaceuticals, Inc. founded?
Alexion Pharmaceuticals, Inc. was founded in 1992.
What industry is Alexion Pharmaceuticals, Inc. in?
Alexion Pharmaceuticals, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Alexion Pharmaceuticals, Inc. based?
Alexion Pharmaceuticals, Inc. is headquartered in Boston, United States.